Carrie Sun has extensive experience in non-litigation legal matters such as corporate reorganization, M&A, PE/VC, overseas listing and foreign direct investment. Carrie has served companies in the industries of pharmaceutical, manufacturing, telecommunication, automobile, real estate, mining, service, retail, etc.
Carrie has extensive experience in investment & financing and capital market, and some representative projects including: Shenzhen Capital Value Partners Greater Bay Area Opportunity Limited Partnership Fund's acquisition of 2.09% issued shares of Fengxiang Co (09977.HK), Dawnrays Pharma's (02348.HK) selling of shares of AD Pharmaceuticals, TCL Technology Group Corporation and its subsidiaries' acquisition of several domestic companies, Hong Kong Sincere Watch's acquisition of Hainan Boao Lecheng, PanAsialum Holdings Company Limited's (02078.HK) sale of its domestic subsidiaries, representing Haitong in its issuance of short-term private placement bonds to a number of domestic real estate companies, Taiping Financial Holdings Company Limited's investment in ClouDr Group Limited (09955.HK), CLSA's investment in a Hangzhou baby products company, CGN's acquisition of LNG Gas station project, Goldman Sachs' equity acquisition of Shenzhen Mindray and its listing on NYSE and subsequent additional issuances, DBS Bank's private placement investment in Guangdong Jinhao Motorcycle Co., Ltd., Heng Ding and New World's subscription of convertible bonds of an agricultural development company in Sichuan, Thomson's investment in Konka Group, Hyosung's acquisition of a Chinese transformer manufacturer, Ashmore Investment Management Limited's acquisition of Shenzhen Minrui Agriculture Products Distribution Chain Business Co., Ltd., 7 Days Inn's introduction of the first batch (Warburg Pincus) and the second batch (Merrill Lynch) of financial investors, Ping An's investment in Ciming Health Checkup Center, Actis' investment in a large-scale electronic product manufacturing enterprise in Huizhou, DCH Holdings' acquisition of a famous 4S store in Shenzhen, US Rotorcraft Companies and Chinese companies' direct investment in the establishment of a domestic aircraft manufacturing company, China Overseas Holdings Limited's overseas bond issuance, the public listing on the NYSE and follow-on offerings of Mindray International; the public offering and listing on the Main Board of the HKEX of Belle International, Yide International (01396.HK), Wuzhou International (01369.HK), Hung Fook Tong (01446.HK), Ten Pao Group (01979.HK), Vincent Medical Holdings (01612.HK), Smart-Core Holdings (02166.HK), Mengke Holdings (01629.HK), Trio Industrial Electronics (01710.HK), Oneforce Holdings (01933.HK), Tian Chang Group (02182.HK), Tian Yuan Group (06119.HK), Maike Tube Industry Holdings Limited (01553.HK), Nayuki Holdings Limited (02150.HK) and General Education (02175.HK); the public listing on the Growth Enterprise Market of the HKEX of Golden Power Group Holdings Limited (03919.HK) and ZC Tech GP (08511.HK); the initial public offering and listing on NASDAQ of Connect Biopharma (CNTB.US), Jin Medical International Ltd. (ZJYL.US) and ZJK Industrial Co., Ltd. (ZJK.US); MicroPort Scientific Corporation's (00853.HK) overseas issuance of USD convertible bonds, etc.
Carrie has been a professional lawyer since 1999. Prior to joining Global Law Office, Carrie worked in several top-tiered law firms - King & Wood, Clifford Chance Hong Kong Office, Norton Rose Beijing Office, and Jun He Law Offices.
Admitted in the PRC (2001)
University of London, LL.M.
Peking University School of Law, LL.B.
Carrie was named one of 15 Top Female Lawyers of Year 2015 in China by Asia Legal Business; List of Thousands of Foreign-related Lawyers in China; Guangdong Province Leading Talent Pool of Foreign-related Lawyer; Shenzhen Leading Talents of Foreign-related Lawyer; and recognized by the The Legal 500 as Highly Recommended Chinese Lawyers in corporate and capital markets for several years since Year 2019.
Arbitrator of the Shenzhen Court of International Arbitration
